X4 PHARMACEUTICALS INC (XFOR) Stock Income Statement
NASDAQ:XFOR - Nasdaq - US98420X1037 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 31.36M | 2.56M | 0.00 | 0.00 | 0.00 | |||
| Cost Of Goods | 5.51M | 797.00K | N/A | N/A | N/A | |||
| Gross Profit | 25.85M | 1.76M | N/A | N/A | N/A | |||
| Operating Expenses | 139.41M | 143.16M | 107.52M | 88.08M | 75.35M | |||
| Research and Development | 80.30M | 81.64M | 72.02M | 61.06M | 50.65M | |||
| Selling, General, and Administrative Expenses | 59.10M | 61.52M | 35.51M | 27.02M | 24.70M | |||
| Operating Income | -113.56M | -141.40M | -107.52M | -88.08M | -75.35M | |||
| Interest Income/Expense | -3.37M | -3.00M | 5.88M | -2.07M | -4.00M | |||
| Other Income/Expense | 26.84M | 2.26M | 554.00K | -4.20M | 430.00K | |||
| Non Recurring Items | N/A | 105.00M | 0.00 | 510.00K | -9.76M | |||
| Income Before Taxes | 14.92M | -37.14M | -101.09M | -93.84M | -88.68M | |||
| Income Tax | 325.00K | 310.00K | 78.00K | 30.00K | 20.00K | |||
| Net Income | 14.60M | -37.45M | -101.17M | -96.41M | -102.64M | |||
| EBITDA | -112.34M | -140.60M | -107.10M | -87.57M | -74.85M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 2.25 | -5.59 | -17.07 | -45.53 | -119.59 | |||
| Non GAAP EPS | -13.46 | -21.30 | -18.00 | -56.10 | -111.00 | |||
| Statistics | ||||||||
| Gross Profit Margin | 82.42% | 68.83% | N/A | N/A | N/A | |||
| Profit Margin | 46.54% | -1464.61% | N/A | N/A | N/A | |||
| Operating Profit Margin | -362.06% | -5529.96% | N/A | N/A | N/A | |||
All data in USD